OP
CLPT icon

ORG Partners’s ClearPoint Neuro CLPT Stock Holding History

ORG Partners’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$957 Buy
70
+15
+27% +$278 ﹤0.01% 1544
2025
Q3 		$1.2K Sell
55
-5
-8% -$59 ﹤0.01% 1377
2025
Q2 		$1.13K Buy
60
+40
+200% +$503 ﹤0.01% 1319
2025
Q1 		$261 Buy
+20
New +$311 ﹤0.01% 1327

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
FCM
FirstWave Capital Management Miami, Florida $94.1M AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

ORG Partners's CLPT Position: Q4 2025 in Review

ORG Partners increased its ClearPoint Neuro (CLPT) stake by 27% in Q4 2025, buying an estimated $278 and bringing the position to 70 shares worth $957. The position accounts for ﹤0.01% of the portfolio, ranked #1544.

ORG Partners first reported a position in CLPT in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.2K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q4 2025.

  • ORG Partners held 70 shares of ClearPoint Neuro worth $957 as of Q4 2025.
  • ORG Partners bought 15 ClearPoint Neuro shares in Q4 2025, an estimated $278.
  • ClearPoint Neuro made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1544 holding.
  • ORG Partners first reported a position in ClearPoint Neuro in Q1 2025 and has held it in 4 quarters since.
  • ORG Partners's ClearPoint Neuro position peaked at $1.2K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.